Imagine a world in which a tiny nanorobot could deliver a specific cannabinoid directly to your endocannabinoid (ECS) receptors. The nanorobot would be thousands of times smaller than the breadth of a human hair and could carry its small cargo inside a single droplet of liquid to deliver it directly to a target cell such as a cancer cell.
The Cell Expansion Market report upholds the future market predictions related to Cell Expansion market size, revenue, production, Consumption, gross margin and other substantial factors.
Nearly three years after okaying the CAR-Ts Yescarta and Kymriah, the FDA has approved a new CD19 therapy. MorphoSys Monjuvi, or tafasitamab-cxix, was cleared Friday for use in refractory diffuse large B-cell lymphoma (DBLCL)
Founded in 1964, the UKs Cystic Fibrosis Trust offers support and resources to patients affected by cystic fibrosis (CF), as well as funding research into treatments and the search for a cure for CF; and ensuring that CF patients can receive appropriate care and therapy. Cystic Fibrosis Trust Director of Research Dr Lucy Allen tells HEQ about the Trusts research strategy and the implications of precision treatment
Every year, the first week of August is observed as World Breastfeeding Week which aims at raising awareness about the benefits of breastfeeding. This year the theme is support breastfeeding for a healthier planet. Breastfeeding is the act of providing sustenance to an infant
The Global Stem Cells Cryopreservation Equipments Market has witnessed continuous growth in the past few years and is projected to grow even further during the forecast period (2020-2025). The assessment provides a 360 view and insights, outlining the key outcomes of the industry, current scenario witnesses a slowdown and study aims to unique strategies followed by key players. These insights also help the business decision-makers to formulate better business plans and make informed decisions for improved profitability.
Stem Cell Therapy Market is worth USD 11.99 billion in 2016 and is expected to reach USD 60.94 billion by 2022, growing at a CAGR of 31.1% from 2016 to 2022.
Synthetic Stem Cells Market report covers the Introduction, Product Type and Application, Market Overview, Market Analysis by Countries, Market Opportunities, Market Risk and Market Driving Force.
Higher Steaks, a UK-based startup, has produced the first samples of cultivated (cell-based) bacon and pork belly. The pork belly is approximately 50 percent cultivated meat to 50 percent plant-based while the bacon is around 70 percent cultivated meat to 30 percent plant-based
On July 24, the Food and Drug Administration (FDA) granted accelerated approval of a new CAR-T therapy, Tecartus (brexucabtagene autoleucel), for adults with mantle cell lymphoma who have not responded to or who have relapsed after other kinds of treatment. Tecartus (formerly known as KTE-X19), manufactured by Kite, a Gilead Company, is a living drug that reprograms a patients own T cells to fight cancer. About two thirds of participants treated in the ZUMA-2 study experienced complete remission, which in a majority of cases lasted at least a year.
Recent Comments